A clinical trial to study the effect of two drugs devadarvyadi kashayam and bharangyadi kashayam in patients with difficulty in breathing

Efficacy Of Devadarvyadi Kashaya In The Management Of Tamaka Shwasa An Open Randomized Controlled clinical trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017168

Enrollment

Registered

2019-01-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma Health Condition 2: null- Tamaka shwasa

Interventions

Intervention1: Devadarvyadi kashaya: 30ml thrice a day with luke warm water oral administration after food for 30 days Control Intervention1: Bharangyadi kashya: 30ml thrice a day with luke warm wate

Eligibility

Inclusion criteria

Inclusion criteria: • Subjects with diagnostic features of Tamaka Å?vÄ?sa • Subjects fulfilling GINA Guideline • Subjects of either sex aged between 20 to 70 years. • Newly diagnosed as well as subjects with known history of stable • FEV1 of • Patients willing to participate with written consent

Exclusion criteria

Exclusion criteria: •Patients with Status Asthamaticus •The patients diagnosed with Tuberculosis, Cardiac Asthma, Chroni •Other Primary Pulmonary diseases like COPD, ILD etc •Patients with uncontrolled Hypertension, Diabetes mellitus •History of Hypersensitivity to the trial drug or any of its ingredients

Design outcomes

Primary

Measure	Time frame
CBC ESR AEC SPIROMETRYTimepoint: on the 0th day and 31st day	—

Secondary

Measure	Time frame
Dyspnea scale wheeze cough scale chest tightness Timepoint: on the 0th day and 31st day	—

Countries

India

Contacts

Public ContactDr Kiran Kumar V Mutnali

KAHER

drkiranmutnali@gmail.com9164648888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026